Chemoembolization for primary and metastatic liver cancer

Area of Science:

• Interventional Radiology
• Oncology
• Hepatobiliary Medicine

Background:

• Transcatheter arterial chemoembolization (TACE) is a standard palliative treatment for primary and metastatic liver cancer.
• Hepatic malignancies represent a significant global health challenge requiring effective therapeutic options.

Purpose of the Study:

• To review the technical aspects, patient selection criteria, and outcomes of TACE.
• To explore the emerging technique of TACE with drug-eluting microspheres for liver cancer.
• To discuss future directions for both TACE modalities in managing hepatic malignancies.

Main Methods:

• Review of current literature and clinical practices regarding TACE.
• Analysis of data pertaining to TACE with drug-eluting microspheres.
• Synthesis of information on patient selection and procedural techniques.

Main Results:

• TACE is widely utilized for palliative care in liver cancer.
• TACE with drug-eluting microspheres demonstrates increasing global adoption.
• Established protocols and emerging data guide the application of these treatments.

Conclusions:

• TACE remains a cornerstone in the palliative management of hepatic tumors.
• TACE with drug-eluting microspheres represents a significant advancement in locoregional therapy.
• Continued research and technical refinement are crucial for optimizing outcomes in liver cancer treatment.